CASI Pharmaceuticals
CASI
#9475
Rank
C$63.78 M
Marketcap
$4.13
Share price
-5.30%
Change (1 day)
-54.45%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -C$40.2 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$22.05 Million. In 2023 the company made an earning of -C$38.05 Million, an increase over its 2022 earnings that were of -C$54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$40.2 Million5.65%
2023 -C$38.05 Million-29.55%
2022 -C$54 Million4.43%
2021 -C$51.71 Million-24.56%
2020 -C$68.54 Million4.74%
2019 -C$65.44 Million65.13%
2018 -C$39.64 Million155.07%
2017 -C$15.54 Million13.93%
2016 -C$13.64 Million31.18%
2015 -C$10.4 Million-72.5%
2014 -C$37.8 Million356.62%
2013 -C$8.28 Million-60.55%
2012 -C$20.99 Million218.41%
2011 -C$6.59 Million0.74%
2010 -C$6.55 Million-32.54%
2009 -C$9.7 Million-66.98%
2008 -C$29.37 Million-14.22%
2007 -C$34.24 Million7.04%
2006 -C$31.99 Million27.95%
2005 -C$25 Million4.51%
2004 -C$23.92 Million-15.84%
2003 -C$28.42 Million-55.29%
2002 -C$63.57 Million-34.05%
2001 -C$96.39 Million31.73%
2000 -C$73.17 Million31.56%
1999 -C$55.62 Million145.56%
1998 -C$22.65 Million76.4%
1997 -C$12.84 Million36.92%
1996 -C$9.38 Million